skip to main content

H.R. 5021 (115th): Stop Online Opioid Sales Act of 2018

The text of the bill below is as of Feb 14, 2018 (Introduced).


I

115th CONGRESS

2d Session

H. R. 5021

IN THE HOUSE OF REPRESENTATIVES

February 14, 2018

introduced the following bill; which was referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned

A BILL

To require the Administrator of the Drug Enforcement Administration to make publicly available on the website of the Drug Enforcement Administration a report on the sale of controlled substances and controlled substance analogues by means of the Internet.

1.

Short title

This Act may be cited as the Stop Online Opioid Sales Act of 2018.

2.

Report on controlled substances and controlled substance analogues sold by means of the Internet

Not later than one year after the date of the enactment of this Act, and annually thereafter, the Administrator of the Drug Enforcement Administration shall make publicly available on the website of the Drug Enforcement Administration a report on, for the previous year, the lawful and unlawful sale of controlled substances and controlled substance analogues (as such terms are defined in section 102 of the Controlled Substances Act (21 U.S.C. 802)) by means of the Internet, including the following information:

(1)

The types of controlled substances and controlled substance analogues that were sold, and the number of sales for each such substance.

(2)

The name of each person, entity, or Internet site, whether in the United States or abroad, that knowingly or intentionally delivers, distributes, or dispenses, or offers or attempts to deliver, distribute, or dispense, a controlled substance or controlled substance analogue by means of the Internet, whether lawfully or unlawfully.

(3)

An estimate of the total revenue for all of the vendors described in paragraph (2) for all of the sales described in paragraph (1).